| 000 | 01806 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518011030.0 | ||
| 264 | 0 | _c20200408 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1477-2574 | ||
| 024 | 7 |
_a10.1016/j.hpb.2018.09.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaurent, Lucie | |
| 245 | 0 | 0 |
_aCA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts. _h[electronic resource] |
| 260 |
_bHPB : the official journal of the International Hepato Pancreato Biliary Association _c05 2019 |
||
| 300 |
_a582-588 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBilirubin _xmetabolism |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aCA-19-9 Antigen _xmetabolism |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aSefrioui, David | |
| 700 | 1 | _aBignon, Anne-Laure | |
| 700 | 1 | _aParzy, Aurélie | |
| 700 | 1 | _aSidali, Sabrina | |
| 700 | 1 | _aHassine, Mélanie | |
| 700 | 1 | _aGangloff, Alice | |
| 700 | 1 | _aGalais, Marie-Pierre | |
| 700 | 1 | _aBouhier-Leporrier, Karine | |
| 700 | 1 | _aMichel, Pierre | |
| 700 | 1 | _aDi Fiore, Frédéric | |
| 773 | 0 |
_tHPB : the official journal of the International Hepato Pancreato Biliary Association _gvol. 21 _gno. 5 _gp. 582-588 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.hpb.2018.09.006 _zAvailable from publisher's website |
| 999 |
_c29081318 _d29081318 |
||